Published in Fam Cancer on January 01, 2005
Hereditary and familial colon cancer. Gastroenterology (2010) 4.15
Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology. J Mol Diagn (2006) 2.11
Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer (2007) 1.39
The role of personalized medicine in metastatic colorectal cancer: an evolving landscape. Therap Adv Gastroenterol (2013) 0.98
Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing. J Health Psychol (2011) 0.94
Colonic adenoma risk in familial colorectal cancer--a study of six extended kindreds. Am J Gastroenterol (2008) 0.94
Hereditary and common familial colorectal cancer: evidence for colorectal screening. Dig Dis Sci (2014) 0.92
Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial. J Clin Oncol (2014) 0.92
Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer. Prev Chronic Dis (2015) 0.89
Anticipation in lynch syndrome: where we are where we go. Curr Genomics (2011) 0.87
Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer (2010) 0.86
Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer (2011) 0.85
Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer. J Med Genet (2010) 0.83
Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC Cancer (2014) 0.83
The familiality of pelvic organ prolapse in the Utah Population Database. Int Urogynecol J (2012) 0.82
Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay. Fam Cancer (2009) 0.82
How many diseases are colorectal cancer? Gastroenterol Res Pract (2012) 0.81
Identification of rare germline copy number variations over-represented in five human cancer types. Mol Cancer (2015) 0.78
Who Needs Follow-Up after Endoscopic Resection of Colorectal Adenomas? Viszeralmedizin (2014) 0.75
KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors. Mol Cell Biol (2016) 0.75
Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia. Br J Cancer (2017) 0.75
Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening? BMC Public Health (2017) 0.75
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94
Hereditary colorectal cancer. N Engl J Med (2003) 11.86
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum (1991) 9.82
A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol (2001) 4.61
Colorectal cancer: molecules and populations. J Natl Cancer Inst (1999) 4.39
Alleles of the APC gene: an attenuated form of familial polyposis. Cell (1993) 3.84
Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01
The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology (2001) 2.68
Colon cancer screening. Gastroenterology (2000) 2.01
Genetic distances between the Utah Mormons and related populations. Am J Hum Genet (1984) 1.79
Biomedical databases: protecting privacy and promoting research. Trends Biotechnol (2003) 1.66
Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer. Gastroenterology (1995) 1.39
Genetic structure of the Utah Mormons: comparison of results based on RFLPs, blood groups, migration matrices, isonymy, and pedigrees. Hum Biol (1994) 1.35
Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology (2004) 1.22
The genetic structure of the Utah Mormons: migration analysis. Hum Biol (1982) 0.99
Genetic heterogeneity and unmapped genes for colorectal cancer. Cancer Res (1996) 0.82
Current status of genetic testing for colorectal cancer susceptibility. Oncology (Williston Park) (2002) 0.77
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Hereditary and familial colon cancer. Gastroenterology (2010) 4.15
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) (2010) 2.86
A two-step model for colon adenoma initiation and progression caused by APC loss. Cell (2009) 2.80
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer (2007) 2.36
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer. Genes Chromosomes Cancer (2011) 2.14
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med (2011) 1.93
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Maximum-likelihood estimation of recent shared ancestry (ERSA). Genome Res (2011) 1.88
CpG island methylation in colorectal cancer: past, present and future. Patholog Res Int (2011) 1.62
Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology (2009) 1.61
Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer (2013) 1.56
Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: a theory-based model. Ann Behav Med (2014) 1.49
Conditional deletion of beta1 integrins in the intestinal epithelium causes a loss of Hedgehog expression, intestinal hyperplasia, and early postnatal lethality. J Cell Biol (2006) 1.44
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin (2006) 1.33
Genetic testing for inherited colon cancer. Gastroenterology (2005) 1.29
Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis (2007) 1.28
Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology (2004) 1.22
Lynch syndrome screening implementation: business analysis by a healthcare system. Am J Manag Care (2011) 1.19
Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol (2009) 1.18
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res (2008) 1.18
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res (2008) 1.17
Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol (2006) 1.17
Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer (2009) 1.17
Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol (2004) 1.14
Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med (2011) 1.13
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion. Fam Cancer (2005) 1.13
Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem (2006) 1.13
Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum. Arch Pathol Lab Med (2013) 1.11
Microsatellite instability and colorectal cancer. Arch Pathol Lab Med (2011) 1.10
American founder mutation for attenuated familial adenomatous polyposis. Clin Gastroenterol Hepatol (2007) 1.10
p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry. Appl Immunohistochem Mol Morphol (2004) 1.09
Systemic mastocytosis in a patient with Cowden syndrome. Am J Hematol (2014) 1.08
Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer (2009) 1.03
Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families. Am J Gastroenterol (2007) 1.03
Colorectal cancer screening. J Natl Compr Canc Netw (2013) 1.02
Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer (2010) 1.02
Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes. Hum Mutat (2010) 1.02
Genetic admixture among Hispanics and candidate gene polymorphisms: potential for confounding in a breast cancer study? Cancer Epidemiol Biomarkers Prev (2007) 0.97
A population-based description of familial clustering of pancreatic cancer. Clin Gastroenterol Hepatol (2010) 0.97
Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome. Dig Dis Sci (2007) 0.96
Quantitative evaluation of CpG island methylation in hyperplastic polyps. Mod Pathol (2009) 0.96
Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype. Fam Cancer (2004) 0.95
Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing. J Health Psychol (2011) 0.94
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc (2014) 0.94
Colonic adenoma risk in familial colorectal cancer--a study of six extended kindreds. Am J Gastroenterol (2008) 0.94
Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.94
The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene. Genes Chromosomes Cancer (2012) 0.93
Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer (2011) 0.92
Hereditary and common familial colorectal cancer: evidence for colorectal screening. Dig Dis Sci (2014) 0.92
Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial. J Clin Oncol (2014) 0.92
A PIK3CA pyrosequencing-based assay that excludes pseudogene interference. J Mol Diagn (2011) 0.91
Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.90
A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol (2007) 0.90
Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer (2007) 0.88
Gonadal mosaicism and familial adenomatous polyposis. Fam Cancer (2007) 0.87
Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark (2007) 0.87
Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer (2010) 0.86
Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum (2013) 0.86
Colorectal Cancer Screening Clinical Practice Guidelines. J Natl Compr Canc Netw (2006) 0.86
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum (2014) 0.85
Avoidance of pseudogene interference in the detection of 3' deletions in PMS2. Hum Mutat (2011) 0.85
Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer (2011) 0.85
Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int J Mol Epidemiol Genet (2010) 0.85
Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism. Int J Cancer (2007) 0.85
Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation. Am J Surg Pathol (2015) 0.84
Who should have genetic testing for the Lynch syndrome? Ann Intern Med (2011) 0.83
Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer. J Med Genet (2010) 0.83
A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Int J Radiat Oncol Biol Phys (2009) 0.83
Extra-abdominal desmoid tumors associated with familial adenomatous polyposis. Sarcoma (2012) 0.83
Missense mismatch repair gene alterations, microsatellite instability, and hereditary nonpolyposis colorectal cancer. J Clin Oncol (2002) 0.83
Gastrointestinal Polyposis in Cowden Syndrome. J Clin Gastroenterol (2017) 0.82
MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog (2009) 0.82
Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors. J Genet Couns (2010) 0.81
How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med (2011) 0.79
Shared genomic segment analysis: the power to find rare disease variants. Ann Hum Genet (2012) 0.79
Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol (2005) 0.79
Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction. J Mol Diagn (2008) 0.79
Large intron 14 rearrangement in APC results in splice defect and attenuated FAP. Hum Genet (2009) 0.78
Epidermal growth factor receptor pathway mutations and colorectal cancer therapy. Arch Pathol Lab Med (2011) 0.78
Colorectal cancer screening. Surg Clin North Am (2002) 0.77
Current status of genetic testing for colorectal cancer susceptibility. Oncology (Williston Park) (2002) 0.77
Somatic mosaicism: a cause for unexplained cases of FAP? Gut (2008) 0.77
Diagnostic Challenges Caused by Endoscopic Biopsy of Colonic Polyps: A Systematic Evaluation of Epithelial Misplacement With Review of Problematic Polyps From the Bowel Cancer Screening Program, United Kingdom. Am J Surg Pathol (2016) 0.77